Details for Patent: 5,849,726
✉ Email this page to a colleague
Summary for Patent: 5,849,726
Title: | Anhydrous alendronate monosodium salt formulations |
Abstract: | Disclosed is a method for treating and preventing bone loss in patients by administering a formulation of anhydrous alendronate sodium. Also described is a pharmaceutical dosage form of said anhydrous alendronate sodium, being anhydrous 4-amino-1-hydroxy-butylidene-1,1-bisphosphonic acid, monosodium salt, in a pharmaceutically acceptable excipient. |
Inventor(s): | Brenner; Gerald S. (Norristown, PA), Ostovic; Drazen (Lansdale, PA), Oberholtzer, Jr.; Earl R. (Hatfield, PA), Thies; J. Eric (Scotch Plains, NJ) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 08/973,386 |
Patent Claim Types: see list of patent claims | Composition; Compound; Use; |
Drugs Protected by US Patent 5,849,726
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,849,726
PCT Information | |||
PCT Filed | June 03, 1996 | PCT Application Number: | PCT/US96/08284 |
PCT Publication Date: | December 12, 1996 | PCT Publication Number: | WO96/39149 |
International Family Members for US Patent 5,849,726
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 289199 | ⤷ Try a Trial | |||
Australia | 5886096 | ⤷ Try a Trial | |||
Canada | 2221417 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |